The effects of angiotensin-converting enzyme inhibitors on peritoneal protein loss and solute transport in peritoneal dialysis patients
OBJECTIVE: The objective of this study was to examine the effects of angiotensin-converting enzyme inhibitors on peritoneal membrane transport, peritoneal protein loss, and proteinuria in peritoneal dialysis patients. METHODS: Fifty-four peritoneal dialysis patients were included in the study. The patients were divided into two groups. Group 1 (n = 34) was treated with angiotensin-converting enzyme inhibitors. Group 2 (n = 20) did not receive any antihypertensive drugs during the entire follow-up. Eleven patients were excluded from the study thereafter. Thus, a total of 30 patients in Group 1 and 13 patients in Group 2 completed the study. We observed the patients for six months. Group 1 patients received maximal doses of angiotensin-converting enzyme inhibitors for six months. Parameters at the beginning of study and at the end of six months were evaluated. RESULTS: At the end of six months, total peritoneal protein loss in 24-hour dialysate effluent was significantly decreased in Group 1, whereas it was increased in Group 2. Compared to the baseline level, peritoneal albumin loss in 24-hour dialysate effluent and 4-hour D/P creatinine were significantly increased in Group 2 but were not significantly changed in Group 1. A covariance analysis between the groups revealed a significant difference only in the decreased amount of total protein loss in 24-hour dialysate. Proteinuria was decreased significantly in Group 1. CONCLUSION: This study suggests that angiotensin-converting enzyme inhibitors reduce peritoneal protein loss and small-solute transport and effectively protect peritoneal membrane transport in peritoneal dialysis patients.
Main Authors: | , , , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Faculdade de Medicina / USP
2012
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322012000800004 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S1807-59322012000800004 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S1807-593220120008000042012-08-30The effects of angiotensin-converting enzyme inhibitors on peritoneal protein loss and solute transport in peritoneal dialysis patientsBasturk,TanerUnsal,AbdulkadirKoc,YenerNezaket,ErenAhbap,ElbisSakaci,TamerSevinc,Mustafa Angiotensin-converting enzyme inhibitors peritoneal protein loss peritoneal transport OBJECTIVE: The objective of this study was to examine the effects of angiotensin-converting enzyme inhibitors on peritoneal membrane transport, peritoneal protein loss, and proteinuria in peritoneal dialysis patients. METHODS: Fifty-four peritoneal dialysis patients were included in the study. The patients were divided into two groups. Group 1 (n = 34) was treated with angiotensin-converting enzyme inhibitors. Group 2 (n = 20) did not receive any antihypertensive drugs during the entire follow-up. Eleven patients were excluded from the study thereafter. Thus, a total of 30 patients in Group 1 and 13 patients in Group 2 completed the study. We observed the patients for six months. Group 1 patients received maximal doses of angiotensin-converting enzyme inhibitors for six months. Parameters at the beginning of study and at the end of six months were evaluated. RESULTS: At the end of six months, total peritoneal protein loss in 24-hour dialysate effluent was significantly decreased in Group 1, whereas it was increased in Group 2. Compared to the baseline level, peritoneal albumin loss in 24-hour dialysate effluent and 4-hour D/P creatinine were significantly increased in Group 2 but were not significantly changed in Group 1. A covariance analysis between the groups revealed a significant difference only in the decreased amount of total protein loss in 24-hour dialysate. Proteinuria was decreased significantly in Group 1. CONCLUSION: This study suggests that angiotensin-converting enzyme inhibitors reduce peritoneal protein loss and small-solute transport and effectively protect peritoneal membrane transport in peritoneal dialysis patients.info:eu-repo/semantics/openAccessFaculdade de Medicina / USPClinics v.67 n.8 20122012-08-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322012000800004en10.6061/clinics/2012(08)04 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Basturk,Taner Unsal,Abdulkadir Koc,Yener Nezaket,Eren Ahbap,Elbis Sakaci,Tamer Sevinc,Mustafa |
spellingShingle |
Basturk,Taner Unsal,Abdulkadir Koc,Yener Nezaket,Eren Ahbap,Elbis Sakaci,Tamer Sevinc,Mustafa The effects of angiotensin-converting enzyme inhibitors on peritoneal protein loss and solute transport in peritoneal dialysis patients |
author_facet |
Basturk,Taner Unsal,Abdulkadir Koc,Yener Nezaket,Eren Ahbap,Elbis Sakaci,Tamer Sevinc,Mustafa |
author_sort |
Basturk,Taner |
title |
The effects of angiotensin-converting enzyme inhibitors on peritoneal protein loss and solute transport in peritoneal dialysis patients |
title_short |
The effects of angiotensin-converting enzyme inhibitors on peritoneal protein loss and solute transport in peritoneal dialysis patients |
title_full |
The effects of angiotensin-converting enzyme inhibitors on peritoneal protein loss and solute transport in peritoneal dialysis patients |
title_fullStr |
The effects of angiotensin-converting enzyme inhibitors on peritoneal protein loss and solute transport in peritoneal dialysis patients |
title_full_unstemmed |
The effects of angiotensin-converting enzyme inhibitors on peritoneal protein loss and solute transport in peritoneal dialysis patients |
title_sort |
effects of angiotensin-converting enzyme inhibitors on peritoneal protein loss and solute transport in peritoneal dialysis patients |
description |
OBJECTIVE: The objective of this study was to examine the effects of angiotensin-converting enzyme inhibitors on peritoneal membrane transport, peritoneal protein loss, and proteinuria in peritoneal dialysis patients. METHODS: Fifty-four peritoneal dialysis patients were included in the study. The patients were divided into two groups. Group 1 (n = 34) was treated with angiotensin-converting enzyme inhibitors. Group 2 (n = 20) did not receive any antihypertensive drugs during the entire follow-up. Eleven patients were excluded from the study thereafter. Thus, a total of 30 patients in Group 1 and 13 patients in Group 2 completed the study. We observed the patients for six months. Group 1 patients received maximal doses of angiotensin-converting enzyme inhibitors for six months. Parameters at the beginning of study and at the end of six months were evaluated. RESULTS: At the end of six months, total peritoneal protein loss in 24-hour dialysate effluent was significantly decreased in Group 1, whereas it was increased in Group 2. Compared to the baseline level, peritoneal albumin loss in 24-hour dialysate effluent and 4-hour D/P creatinine were significantly increased in Group 2 but were not significantly changed in Group 1. A covariance analysis between the groups revealed a significant difference only in the decreased amount of total protein loss in 24-hour dialysate. Proteinuria was decreased significantly in Group 1. CONCLUSION: This study suggests that angiotensin-converting enzyme inhibitors reduce peritoneal protein loss and small-solute transport and effectively protect peritoneal membrane transport in peritoneal dialysis patients. |
publisher |
Faculdade de Medicina / USP |
publishDate |
2012 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322012000800004 |
work_keys_str_mv |
AT basturktaner theeffectsofangiotensinconvertingenzymeinhibitorsonperitonealproteinlossandsolutetransportinperitonealdialysispatients AT unsalabdulkadir theeffectsofangiotensinconvertingenzymeinhibitorsonperitonealproteinlossandsolutetransportinperitonealdialysispatients AT kocyener theeffectsofangiotensinconvertingenzymeinhibitorsonperitonealproteinlossandsolutetransportinperitonealdialysispatients AT nezaketeren theeffectsofangiotensinconvertingenzymeinhibitorsonperitonealproteinlossandsolutetransportinperitonealdialysispatients AT ahbapelbis theeffectsofangiotensinconvertingenzymeinhibitorsonperitonealproteinlossandsolutetransportinperitonealdialysispatients AT sakacitamer theeffectsofangiotensinconvertingenzymeinhibitorsonperitonealproteinlossandsolutetransportinperitonealdialysispatients AT sevincmustafa theeffectsofangiotensinconvertingenzymeinhibitorsonperitonealproteinlossandsolutetransportinperitonealdialysispatients AT basturktaner effectsofangiotensinconvertingenzymeinhibitorsonperitonealproteinlossandsolutetransportinperitonealdialysispatients AT unsalabdulkadir effectsofangiotensinconvertingenzymeinhibitorsonperitonealproteinlossandsolutetransportinperitonealdialysispatients AT kocyener effectsofangiotensinconvertingenzymeinhibitorsonperitonealproteinlossandsolutetransportinperitonealdialysispatients AT nezaketeren effectsofangiotensinconvertingenzymeinhibitorsonperitonealproteinlossandsolutetransportinperitonealdialysispatients AT ahbapelbis effectsofangiotensinconvertingenzymeinhibitorsonperitonealproteinlossandsolutetransportinperitonealdialysispatients AT sakacitamer effectsofangiotensinconvertingenzymeinhibitorsonperitonealproteinlossandsolutetransportinperitonealdialysispatients AT sevincmustafa effectsofangiotensinconvertingenzymeinhibitorsonperitonealproteinlossandsolutetransportinperitonealdialysispatients |
_version_ |
1756432168105541632 |